NEW YORK ( TheStreet) -- TheStreet's Brittany Umar reports shares of CVS Caremark ( CVS)  climbing after the drugstore and pharmacy chain reported fourth-quarter earnings that beat analysts forecasts.  The company said pharmacy revenue at its established drugstores grew 6.8% during the quarter.  

VIDEO TRANSCRIPT:

Shares of CVS Caremark ( CVS) are climbing after the drugstore and pharmacy chain reported fourth-quarter earnings rose more than 12% over the same period a year ago.

The company said results were boosted by pharmacy revenue at its established drugstores, which grew nearly 7% during the quarter.  CVS managed to fill almost 4% more prescriptions and sell more generic drugs despite two main challenges.  The company processed fewer network claims and saw a decline in store traffic, which prompted a nearly 2% slide in sales of general merchandise.

Overall, revenue in the period rose 4.6% to about $32.8 billion, beating analyst forecasts of about $32.6 billion, according to Thomson Reuters.

Last week, CVS became the first U.S. drugstore chain to announce it would stop selling cigarettes and other tobacco products.  It plans to take the products off all of its shelves by October.

Shares of CVS were most recently climbing about 2% to $68.34.

In New York, I'm Brittany Umar for TheStreet.

-- Written by Brittany Umar in New York.

If you liked this article you might like

It's Dumb to Think Amazon Will Be Able to Skirt Regulators Forever

It's Dumb to Think Amazon Will Be Able to Skirt Regulators Forever

Jim Cramer: You Have to Decide If You Want to Profit From This Moment

Jim Cramer: You Have to Decide If You Want to Profit From This Moment

Walmart Sinks Dow; Albertsons to Fight Off Grocery Struggles With Rite Aid-ICYMI

Walmart Sinks Dow; Albertsons to Fight Off Grocery Struggles With Rite Aid-ICYMI

Rite Aid Pops After Albertsons Plans to Buy Part of Drugstore Chain

Rite Aid Pops After Albertsons Plans to Buy Part of Drugstore Chain

Goldman Bankers (Mostly) Upbeat on Tech M&A and IPO Trends

Goldman Bankers (Mostly) Upbeat on Tech M&A and IPO Trends